Literature DB >> 32443358

Loss to follow-up and opportunities for reengagement in HIV care in rural Mozambique: A prospective cohort study.

Laura Fuente-Soro1,2, Elisa López-Varela1,2, Orvalho Augusto1, Edson Luis Bernardo1,3, Charfudin Sacoor1, Ariel Nhacolo1, Paula Ruiz-Castillo2, Charity Alfredo4, Esmeralda Karajeanes5, Paula Vaz5, Denise Naniche1,2.   

Abstract

Patients lost to follow-up (LTFU) over the human immunodeficiency virus (HIV) cascade have poor clinical outcomes and contribute to onward HIV transmission. We assessed true care outcomes and factors associated with successful reengagement in patients LTFU in southern Mozambique.Newly diagnosed HIV-positive adults were consecutively recruited in the Manhiça District. Patients LTFU within 12 months after HIV diagnosis were visited at home from June 2015 to July 2016 and interviewed for ascertainment of outcomes and reasons for LTFU. Factors associated with reengagement in care within 90 days after the home visit were analyzed by Cox proportional hazards model.Among 1122 newly HIV-diagnosed adults, 691 (61.6%) were identified as LTFU. Of those, 557 (80.6%) were approached at their homes and 321 (57.6%) found at home. Over 50% had died or migrated, 10% had been misclassified as LTFU, and 252 (78.5%) were interviewed. Following the visit, 79 (31.3%) reengaged in care. Having registered in care and a shorter time between LTFU and visit were associated with reengagement in multivariate analyses: adjusted hazards ratio of 3.54 [95% confidence interval (CI): 1.81-6.92; P < .001] and 0.93 (95% CI: 0.87-1.00; P = .045), respectively. The most frequently reported barriers were the lack of trust in the HIV-diagnosis, the perception of being in good health, and fear of being badly treated by health personnel and differed by type of LTFU.Estimates of LTFU in rural areas of sub-Saharan Africa are likely to be overestimated in the absence of active tracing strategies. Home visits are resource-intensive but useful strategies for reengagement for at least one-third of LTFU patients when applied in the context of differentiated care for those LTFU individuals who had already enrolled in HIV care at some point.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32443358     DOI: 10.1097/MD.0000000000020236

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  5 in total

1.  The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals.

Authors:  Peter Ehrenkranz; Sydney Rosen; Andrew Boulle; Jeffrey W Eaton; Nathan Ford; Matthew P Fox; Anna Grimsrud; Brian D Rice; Izukanji Sikazwe; Charles B Holmes
Journal:  PLoS Med       Date:  2021-05-24       Impact factor: 11.069

2.  Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda.

Authors:  Edwin Nuwagira; Boniface A E Lumori; Rose Muhindo; Michael Kanyesigye; Abdallah Amir; Winnie Muyindike; Conrad Muzoora
Journal:  AIDS Res Ther       Date:  2021-03-20       Impact factor: 2.250

3.  The effect of tracer contact on return to care among adult, "lost to follow-up" patients living with HIV in Zambia: an instrumental variable analysis.

Authors:  Laura K Beres; Aaloke Mody; Kombatende Sikombe; Lauren Hersch Nicholas; Sheree Schwartz; Ingrid Eshun-Wilson; Paul Somwe; Sandra Simbeza; Jake M Pry; Paul Kaumba; John McGready; Charles B Holmes; Carolyn Bolton-Moore; Izukanji Sikazwe; Julie A Denison; Elvin H Geng
Journal:  J Int AIDS Soc       Date:  2021-12       Impact factor: 6.707

4.  Quality of care in a differentiated HIV service delivery intervention in Tanzania: A mixed-methods study.

Authors:  Nwanneka Ebelechukwu Okere; Judith Meta; Werner Maokola; Giulia Martelli; Eric van Praag; Denise Naniche; Gabriela B Gomez; Anton Pozniak; Tobias Rinke de Wit; Josien de Klerk; Sabine Hermans
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

5.  Incidence and factors associated with being lost to follow-up among people living with HIV and receiving antiretroviral therapy in Nyarugenge the central business district of Kigali city, Rwanda.

Authors:  Daniel Ntabanganyimana; Lawrence Rugema; Jared Omolo; Olivier Nsekuye; Samuel Sewava Malamba
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.